Effect of anticoagulants and storage temperature on the stability of receptor activator for nuclear factor-kappa B ligand and osteoprotegerin in plasma and serum.
Chan
Benjamin Y Y
BY
Department of Clinical Chemistry, Royal Liverpool University Hospital, The University of Liverpool, Liverpool, L69 3GA, UK.
Buckley
Katherine A
KA
Durham
Brian H
BH
Gallagher
James A
JA
Fraser
William D
WD
D000925:Anticoagulants; D001800:Blood Specimen Collection; D002352:Carrier Proteins / Q000097:blood*; D004355:Drug Stability; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D008024:Ligands; D008562:Membrane Glycoproteins / Q000097:blood*; D053244:Osteoprotegerin; D010949:Plasma; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear / Q000097:blood*; D018124:Receptors, Tumor Necrosis Factor; D044967:Serum
D000925:Anticoagulants; D002352:Carrier Proteins; D006023:Glycoproteins; D008024:Ligands; D008562:Membrane Glycoproteins; D053244:Osteoprotegerin; D053245:RANK Ligand; D053246:Receptor Activator of Nuclear Factor-kappa B; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C505686:TNFRSF11A protein, human; C506030:TNFRSF11B protein, human; C505688:TNFSF11 protein, human